ClinicalTrials.gov record

Completed Phase 2Phase 3 Interventional Accepts healthy volunteers Results available

Therapy to Elevate CD4 Counts in HIV-1 Disease

ClinicalTrials.gov ID: NCT01370018

Public ClinicalTrials.gov record NCT01370018. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Zemaira (Alpha-1-Proteinase Inhibitor) Therapy in HIV-1 Disease

Study identification

NCT ID: NCT01370018
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: Institute for Human Genetics and Biochemistry; Other
Enrollment: 4 participants

Conditions and interventions

Conditions

HIV Disease

Interventions

alpha-1-Proteinase Inhibitor Biological

Biological

Eligibility (public fields only)

Age range: 30 Years to 70 Years
Sex: Male
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2006
Primary completion: Jan 31, 2007
Completion: Jan 31, 2007
Last update posted: Sep 27, 2021

2006 – 2007

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Cabrini Medical Center	New York	New York	10003	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01370018, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 27, 2021 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01370018 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →